{"id":3388,"date":"2024-04-12T07:03:00","date_gmt":"2024-04-12T07:03:00","guid":{"rendered":"https:\/\/pharm.sinocurechem.com\/?p=3270"},"modified":"2024-04-12T07:03:00","modified_gmt":"2024-04-12T07:03:00","slug":"thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond","status":"publish","type":"post","link":"https:\/\/longchangextracts.com\/hu\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/","title":{"rendered":"Az immunter\u00e1pia forradalmas\u00edt\u00e1sa: A timozin alfa1 felszabad\u00edtja a prec\u00edzi\u00f3s orvostudom\u00e1ny erej\u00e9t a v\u00edrusfert\u0151z\u00e9sek, a r\u00e1k \u00e9s azon t\u00fal!"},"content":{"rendered":"

Timozin alfa1<\/span><\/b><\/b><\/p>\n

\u00c1ttekint\u00e9s:<\/span><\/b><\/b><\/p>\n

A timozin-alfa1 (T-alfa1) egy szintetikus 28 aminosavb\u00f3l \u00e1ll\u00f3, t\u00f6bbf\u00e9le biol\u00f3giai aktivit\u00e1ssal rendelkez\u0151 peptid, amelyet els\u0151sorban az immunv\u00e1lasz fokoz\u00e1s\u00e1ra haszn\u00e1lnak a HBV- \u00e9s hepatitis C-v\u00edrus (HCV) fert\u0151z\u00e9sek kezel\u00e9s\u00e9ben, \u00e9s jelenleg fejleszt\u00e9s alatt \u00e1ll a nem kissejtes t\u00fcd\u0151r\u00e1k (NSCLC), a hepatocellul\u00e1ris karcin\u00f3ma, az AIDS \u00e9s a malignus melanoma kezel\u00e9s\u00e9re. A T-alfa1 fokozza a citokinaktivit\u00e1st \u00e9s cs\u00f6kkenti a citotoxikus gy\u00f3gyszeres kezel\u00e9sek, k\u00f6zt\u00fck a ciklofoszfamid, az 5-fluorouracil \u00e9s a dakarbazin hematotoxicit\u00e1s\u00e1t.<\/span><\/p>\n

A timozin alfa1 egy peptidfragmentum, amely az emberben a PTMA g\u00e9n \u00e1ltal k\u00f3dolt timozin alfa feh\u00e9rj\u00e9b\u0151l sz\u00e1rmazik.<\/span><\/p>\n

Ez az els\u0151 peptid az 5. timopeptidfrakci\u00f3ban, amelyet szekven\u00e1ltak \u00e9s el\u0151\u00e1ll\u00edtottak. A timopeptid alfa1 genetikailag \u00e9s k\u00e9miailag nem kapcsol\u00f3dik a b\u00e9ta-timopeptidhez. A b\u00e9ta-th\u00fcmopeptid egy 28 aminosavb\u00f3l \u00e1ll\u00f3 fragmentum, amely a hosszabb, 113 aminosavb\u00f3l \u00e1ll\u00f3 prothymosin alfa prekurzorb\u00f3l sz\u00e1rmazik.<\/span><\/p>\n

A timozin \u03b11 (T\u03b11) egy szintetikus peptid, amely 28 aminosavb\u00f3l \u00e1ll, \u00e9s a term\u00e9szetes emberi timozin alfa-1 feh\u00e9rj\u00e9b\u0151l sz\u00e1rmazik.<\/span><\/p>\n

Biol\u00f3giailag akt\u00edv polipeptid, amely d\u00f6nt\u0151 szerepet j\u00e1tszik az immunrendszer szab\u00e1lyoz\u00e1s\u00e1ban.<\/span><\/p>\n

A T\u03b11-et k\u00fcl\u00f6nb\u00f6z\u0151 betegs\u00e9gek, t\u00f6bbek k\u00f6z\u00f6tt a kr\u00f3nikus hepatitis B \u00e9s C kezel\u00e9s\u00e9re enged\u00e9lyezt\u00e9k, \u00e9s vizsg\u00e1lt\u00e1k a lehets\u00e9ges felhaszn\u00e1l\u00e1s\u00e1t m\u00e1s eg\u00e9szs\u00e9g\u00fcgyi \u00e1llapotokban is.<\/span><\/p>\n

K\u00e9miai szerkezet \u00e9s tulajdons\u00e1gok:<\/span><\/b><\/b><\/p>\n

Fizikai tulajdons\u00e1gok:<\/span><\/p>\n

Fizikai \u00e1llapot: Liofiliz\u00e1lt por<\/span><\/p>\n

Megjelen\u00e9s: Feh\u00e9r vagy t\u00f6rtfeh\u00e9r por<\/span><\/p>\n

Szag: Szagtalan<\/span><\/p>\n

Molekul\u00e1ris k\u00e9plet: C138H221N39O42S<\/span><\/p>\n

Molekulat\u00f6meg: 3,108.3 g\/mol<\/span><\/p>\n

Oldhat\u00f3s\u00e1g:<\/span>\u00a0<\/span>V\u00edzben, h\u00edg savakban \u00e9s vizes pufferekben old\u00f3dik.<\/span><\/p>\n

Szerves old\u00f3szerekben gyeng\u00e9n old\u00f3dik<\/span><\/p>\n

K\u00e9miai tulajdons\u00e1gok:<\/span><\/b><\/b><\/p>\n

Aminosav szekvencia: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Ser-Glu-Ile-Thr-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Lys-Glu-Thr-Pro-Pro-Pro-Asp-Asp-Asp-Ala-Ala-Ala-NH2<\/span><\/p>\n

Izoelektromos pont (pI): Hozz\u00e1vet\u0151legesen 5,0<\/span><\/p>\n

Nett\u00f3 d\u00edj: Pozit\u00edv fiziol\u00f3gi\u00e1s pH-n a b\u00e1zikus aminosavak (lizin \u00e9s arginin) jelenl\u00e9te miatt.<\/span><\/p>\n

M\u00e1sodlagos szerkezet: T\u00falnyom\u00f3r\u00e9szt alfa-h\u00e9lix \u00e9s v\u00e9letlenszer\u0171 tekercs<\/span><\/p>\n

Stabilit\u00e1s: Viszonylag stabil savas \u00e9s semleges vizes oldatokban, oxid\u00e1ci\u00f3ra \u00e9s h\u0151boml\u00e1sra hajlamos magas h\u0151m\u00e9rs\u00e9kleten.<\/span><\/p>\n

A liofiliz\u00e1lt Thymosin A1 szobah\u0151m\u00e9rs\u00e9kleten 3 h\u00e9tig stabil, de -18\u00b0C-on kell t\u00e1rolni \u00e9s sz\u00e1r\u00edtani. A timopeptidet a rekonstit\u00faci\u00f3t k\u00f6vet\u0151en 2-7 napig 4\u00b0C-on, felhaszn\u00e1l\u00e1s el\u0151tt pedig -18\u00b0C alatt kell t\u00e1rolni.<\/span><\/p>\n

Hossz\u00fa t\u00e1v\u00fa t\u00e1rol\u00e1shoz hordoz\u00f3feh\u00e9rje (0,1% HSA vagy BSA) hozz\u00e1ad\u00e1sa aj\u00e1nlott.<\/span><\/p>\n

K\u00e9rj\u00fck, ker\u00fclje el a fagyaszt\u00e1si-olvad\u00e1si ciklusokat.<\/span><\/p>\n

Fizikai-k\u00e9miai jellemz\u0151k:<\/span><\/b><\/b><\/p>\n

Abszorpci\u00f3s egy\u00fctthat\u00f3: 0,404 (1 mg\/ml, 278 nm)<\/span><\/p>\n

Optikai forgat\u00e1s: [^25_D = -28\u00b0 (c = 1, v\u00edz)<\/span><\/p>\n

Olvad\u00e1spont: Nem j\u00f3l meghat\u00e1rozott a peptid jellege miatt<\/span><\/p>\n

Analitikai technik\u00e1k:<\/span><\/b><\/b><\/p>\n

A timozin \u03b11 jellemz\u00e9s\u00e9re haszn\u00e1lt \u00e1ltal\u00e1nos analitikai technik\u00e1k a k\u00f6vetkez\u0151k:<\/span><\/p>\n

Aminosav-elemz\u00e9s<\/span><\/p>\n

Nagy teljes\u00edtm\u00e9ny\u0171 folyad\u00e9kkromatogr\u00e1fia (HPLC)<\/span><\/p>\n

T\u00f6megspektrometria (MS)<\/span><\/p>\n

Cirkul\u00e1ris dichroizmus (CD) spektroszk\u00f3pia<\/span><\/p>\n

Nukle\u00e1ris m\u00e1gneses rezonancia (NMR) spektroszk\u00f3pia<\/span><\/p>\n

Molekulat\u00f6mege 3 108,3 g\/mol, \u00e9s viszonylag kis m\u00e9ret\u0171, v\u00edzben old\u00f3d\u00f3 peptid.<\/span><\/p>\n

A T\u03b11 egy kationos peptid, amelynek nett\u00f3 pozit\u00edv t\u00f6lt\u00e9se t\u00f6bb b\u00e1zikus aminosavmaradv\u00e1ny (lizin \u00e9s arginin) jelenl\u00e9t\u00e9nek k\u00f6sz\u00f6nhet\u0151.<\/span><\/p>\n

A peptid \u00e9rz\u00e9keny az enzimatikus leboml\u00e1sra, \u00e9s viszonylag r\u00f6vid felez\u00e9si ideje van a szervezetben.<\/span><\/p>\n

Ter\u00e1pi\u00e1s alkalmaz\u00e1sok:<\/span><\/b><\/b><\/p>\n

A timozin \u03b11 a kr\u00f3nikus hepatitis B \u00e9s C kezel\u00e9s\u00e9re enged\u00e9lyezett, ahol kimutatt\u00e1k, hogy jav\u00edtja a klinikai eredm\u00e9nyeket \u00e9s fokozza a v\u00edrusellenes ter\u00e1pi\u00e1k hat\u00e9konys\u00e1g\u00e1t.<\/span><\/p>\n

Vizsg\u00e1lt\u00e1k a k\u00fcl\u00f6nb\u00f6z\u0151 egy\u00e9b \u00e1llapotok, p\u00e9ld\u00e1ul szepszis, r\u00e1k \u00e9s immunhi\u00e1nyos rendelleness\u00e9gek kezel\u00e9s\u00e9ben val\u00f3 lehets\u00e9ges felhaszn\u00e1l\u00e1s\u00e1t is.<\/span><\/p>\n

A folyamatban l\u00e9v\u0151 kutat\u00e1sok a T\u03b11 vakcin\u00e1kkal kombin\u00e1lt adjuv\u00e1ns ter\u00e1piak\u00e9nt val\u00f3 felhaszn\u00e1l\u00e1s\u00e1t vizsg\u00e1lj\u00e1k, mivel fokozhatja az immunv\u00e1laszt \u00e9s jav\u00edthatja a vakcina hat\u00e9konys\u00e1g\u00e1t.<\/span><\/p>\n

1.\u00a0<\/span>Kr\u00f3nikus v\u00edrusos hepatitis:<\/span><\/p>\n

A timozin \u03b11 els\u0151sorban a kr\u00f3nikus hepatitis B \u00e9s C fert\u0151z\u00e9sek kezel\u00e9s\u00e9re enged\u00e9lyezett \u00e9s alkalmazott k\u00e9sz\u00edtm\u00e9ny.<\/span><\/p>\n

Ezekben az indik\u00e1ci\u00f3kban a T\u03b11 bizony\u00edtottan fokozza a gazdaszervezet immunv\u00e1lasz\u00e1t, jav\u00edtja a m\u00e1jfunkci\u00f3t \u00e9s n\u00f6veli a v\u00edrusellenes ter\u00e1pi\u00e1k hat\u00e9konys\u00e1g\u00e1t.<\/span><\/p>\n

A T\u03b11-et gyakran alkalmazz\u00e1k a szok\u00e1sos v\u00edrusellenes gy\u00f3gyszerekkel, p\u00e9ld\u00e1ul interferonnal \u00e9s nukleozid\/nukleotid anal\u00f3gokkal kombin\u00e1lva a kezel\u00e9si eredm\u00e9nyek jav\u00edt\u00e1sa \u00e9rdek\u00e9ben.<\/span><\/p>\n

2.\u00a0<\/span>Immunmodul\u00e1ci\u00f3 \u00e9s immunbetegs\u00e9gek:<\/span><\/p>\n

Az immunrendszer k\u00fcl\u00f6nb\u00f6z\u0151 \u00f6sszetev\u0151inek modul\u00e1l\u00e1s\u00e1ra val\u00f3 k\u00e9pess\u00e9ge miatt a timozin \u03b11-et m\u00e1s immunrendszerrel kapcsolatos rendelleness\u00e9gekben val\u00f3 lehets\u00e9ges alkalmaz\u00e1sa c\u00e9lj\u00e1b\u00f3l is vizsg\u00e1lt\u00e1k, t\u00f6bbek k\u00f6z\u00f6tt:<\/span><\/p>\n

Immunhi\u00e1nyos \u00e1llapotok (pl. HIV\/AIDS, r\u00e1kos megbeteged\u00e9sekkel \u00f6sszef\u00fcgg\u0151 immunszuppresszi\u00f3)<\/span><\/p>\n

Autoimmun betegs\u00e9gek (p\u00e9ld\u00e1ul reum\u00e1s \u00edz\u00fcleti gyullad\u00e1s, sziszt\u00e9m\u00e1s lupus erythematosus)<\/span><\/p>\n

Szepszis \u00e9s fert\u0151z\u0151 betegs\u00e9gek<\/span><\/p>\n

3.\u00a0<\/span>Vakcina adjuv\u00e1ns:<\/span><\/p>\n

A folyamatban l\u00e9v\u0151 kutat\u00e1sok a timozin \u03b11 adjuv\u00e1nsk\u00e9nt val\u00f3 felhaszn\u00e1l\u00e1s\u00e1t vizsg\u00e1lj\u00e1k vakcinaformul\u00e1kban, mivel fokozhatja a k\u00fcl\u00f6nb\u00f6z\u0151 antig\u00e9nekre adott immunv\u00e1laszt.<\/span><\/p>\n

A T\u03b11-et influenza-, hepatitis B- \u00e9s r\u00e1k elleni vakcin\u00e1kkal kombin\u00e1lva vizsg\u00e1lt\u00e1k azzal a c\u00e9llal, hogy jav\u00edts\u00e1k a vakcina hat\u00e9konys\u00e1g\u00e1t \u00e9s meghosszabb\u00edts\u00e1k az immunit\u00e1st.<\/span><\/p>\n

4.\u00a0<\/span>R\u00e1k immunter\u00e1pia:<\/span><\/p>\n

A timozin \u03b11-et mint potenci\u00e1lis immunter\u00e1pi\u00e1s szert vizsg\u00e1lt\u00e1k k\u00fcl\u00f6nb\u00f6z\u0151 r\u00e1kt\u00edpusok, k\u00f6zt\u00fck a t\u00fcd\u0151r\u00e1k, a melanoma \u00e9s a leuk\u00e9mia kezel\u00e9s\u00e9ben.<\/span><\/p>\n

Ezekben az alkalmaz\u00e1sokban a T\u03b11 felhaszn\u00e1lhat\u00f3 az immunrendszer stimul\u00e1l\u00e1s\u00e1ra, az immunsejtek aktivit\u00e1s\u00e1nak fokoz\u00e1s\u00e1ra, \u00e9s potenci\u00e1lisan jav\u00edthatja az egy\u00e9b r\u00e1kellenes kezel\u00e9sekre, p\u00e9ld\u00e1ul a kemoter\u00e1pi\u00e1ra \u00e9s a c\u00e9lzott ter\u00e1pi\u00e1kra adott v\u00e1laszt.<\/span><\/p>\n

5.\u00a0<\/span>Sebgy\u00f3gyul\u00e1s \u00e9s sz\u00f6vetjav\u00edt\u00e1s:<\/span><\/p>\n

Egyes kutat\u00e1sok szerint a timozin \u03b11 szerepet j\u00e1tszhat a sebgy\u00f3gyul\u00e1s \u00e9s a sz\u00f6veti helyre\u00e1ll\u00edt\u00e1si folyamatok el\u0151seg\u00edt\u00e9s\u00e9ben, potenci\u00e1lisan a sejtprolifer\u00e1ci\u00f3ra, a migr\u00e1ci\u00f3ra \u00e9s az angiogenezisre gyakorolt hat\u00e1s\u00e1n kereszt\u00fcl.<\/span><\/p>\n

Ezek a lehets\u00e9ges alkalmaz\u00e1sok m\u00e9g a vizsg\u00e1lat korai szakasz\u00e1ban vannak, \u00e9s tov\u00e1bbi kutat\u00e1sokat \u00e9s klinikai valid\u00e1l\u00e1st ig\u00e9nyelnek.<\/span><\/p>\n

6.\u00a0<\/span>Neurol\u00f3giai rendelleness\u00e9gek:<\/span><\/p>\n

El\u0151zetes vizsg\u00e1latok azt jelezt\u00e9k, hogy a timozin \u03b11 neuroprotekt\u00edv hat\u00e1ssal b\u00edrhat, \u00e9s potenci\u00e1lisan el\u0151ny\u00f6s lehet bizonyos neurol\u00f3giai \u00e1llapotok, p\u00e9ld\u00e1ul az Alzheimer-k\u00f3r \u00e9s a stroke kezel\u00e9s\u00e9ben.<\/span><\/p>\n

A T\u03b11 alkalmaz\u00e1sa neurol\u00f3giai rendelleness\u00e9gekben azonban m\u00e9g mindig a kutat\u00e1s \u00faj ter\u00fclete, \u00e9s kiterjedtebb klinikai vizsg\u00e1latokra van sz\u00fcks\u00e9g ahhoz, hogy meg\u00e1llap\u00edts\u00e1k hat\u00e9konys\u00e1g\u00e1t \u00e9s biztons\u00e1goss\u00e1g\u00e1t ezekben az indik\u00e1ci\u00f3kban.<\/span><\/p>\n

\u00d6sszess\u00e9g\u00e9ben a timozin \u03b11 els\u0151dleges \u00e9s legmegalapozottabb alkalmaz\u00e1sa a kr\u00f3nikus v\u00edrusos hepatitisz, k\u00fcl\u00f6n\u00f6sen a kr\u00f3nikus hepatitisz B \u00e9s C kezel\u00e9s\u00e9re szolg\u00e1l. Lehets\u00e9ges alkalmaz\u00e1sait m\u00e1s ter\u00fcleteken, p\u00e9ld\u00e1ul az immunmodul\u00e1ci\u00f3, a r\u00e1k \u00e9s a neurol\u00f3giai rendelleness\u00e9gek ter\u00fclet\u00e9n jelenleg is akt\u00edvan vizsg\u00e1lj\u00e1k a folyamatban l\u00e9v\u0151 kutat\u00e1sok \u00e9s klinikai vizsg\u00e1latok keret\u00e9ben.<\/span><\/p>\n

Hat\u00e1smechanizmus:<\/span><\/b><\/b><\/p>\n

A timozin \u03b11 biol\u00f3giai hat\u00e1s\u00e1t az immunrendszer k\u00fcl\u00f6nb\u00f6z\u0151 \u00f6sszetev\u0151ivel, k\u00f6zt\u00fck a T-sejtekkel, a dendritikus sejtekkel \u00e9s a term\u00e9szetes \u00f6l\u0151sejtekkel val\u00f3 k\u00f6lcs\u00f6nhat\u00e1s r\u00e9v\u00e9n fejti ki.<\/span><\/p>\n

M\u00f3dos\u00edthatja a citokinek, kemokinek \u00e9s m\u00e1s immunrendszerrel kapcsolatos molekul\u00e1k expresszi\u00f3j\u00e1t \u00e9s m\u0171k\u00f6d\u00e9s\u00e9t, ami fokozott immunv\u00e1laszhoz \u00e9s az immunrendszer jobb m\u0171k\u00f6d\u00e9s\u00e9hez vezet.<\/span><\/p>\n

Kimutatt\u00e1k, hogy a T\u03b11 serkenti a T-sejtek differenci\u00e1l\u00f3d\u00e1s\u00e1t \u00e9s \u00e9r\u00e9s\u00e9t, el\u0151seg\u00edti az interferon-gamma termel\u00e9s\u00e9t, \u00e9s fokozza a term\u00e9szetes \u00f6l\u0151sejtek aktivit\u00e1s\u00e1t.<\/span><\/p>\n

1.\u00a0<\/span>Az immunrendszer modul\u00e1ci\u00f3ja:<\/span><\/b><\/b><\/p>\n

A timozin \u03b11 els\u0151sorban az immunrendszer k\u00fcl\u00f6nb\u00f6z\u0151 komponenseivel val\u00f3 k\u00f6lcs\u00f6nhat\u00e1s \u00e9s azok modul\u00e1l\u00e1sa r\u00e9v\u00e9n fejti ki biol\u00f3giai hat\u00e1s\u00e1t, t\u00f6bbek k\u00f6z\u00f6tt:<\/span><\/p>\n

A.\u00a0<\/span>T-sejtek differenci\u00e1l\u00f3d\u00e1sa \u00e9s \u00e9r\u00e9se:<\/span><\/p>\n

A T\u03b11 el\u0151seg\u00edtheti a T-sejtek, k\u00fcl\u00f6n\u00f6sen a naiv T-sejtek differenci\u00e1l\u00f3d\u00e1s\u00e1t \u00e9s \u00e9r\u00e9s\u00e9t funkcion\u00e1lis effektor \u00e9s mem\u00f3ria T-sejtekk\u00e9.<\/span><\/p>\n

Fokozza a T-sejt-specifikus markerek, p\u00e9ld\u00e1ul a CD3, CD4 \u00e9s CD8 kifejez\u0151d\u00e9s\u00e9t, \u00e9s n\u00f6veli az interleukin-2 (IL-2) termel\u00e9s\u00e9t, amely a T-sejtek aktiv\u00e1ci\u00f3j\u00e1nak \u00e9s prolifer\u00e1ci\u00f3j\u00e1nak kritikus citokinje.<\/span><\/p>\n

B.\u00a0<\/span>Citokin \u00e9s kemokin szab\u00e1lyoz\u00e1s:<\/span><\/p>\n

A T\u03b11 k\u00e9pes modul\u00e1lni k\u00fcl\u00f6nb\u00f6z\u0151 citokinek \u00e9s kemokinek, p\u00e9ld\u00e1ul az interferon-gamma (IFN-\u03b3), a tumor nekr\u00f3zis faktor-alfa (TNF-\u03b1) \u00e9s az interleukin-12 (IL-12) termel\u00e9s\u00e9t \u00e9s szekr\u00e9ci\u00f3j\u00e1t.<\/span><\/p>\n

Ez az immunsejtek, k\u00f6zt\u00fck a T-sejtek, a term\u00e9szetes \u00f6l\u0151sejtek (NK-sejtek) \u00e9s az antig\u00e9n-prezent\u00e1l\u00f3 sejtek (APC-k) fokozott aktiv\u00e1ci\u00f3j\u00e1hoz \u00e9s toborz\u00e1s\u00e1hoz vezethet.<\/span><\/p>\n

C.\u00a0<\/span>Term\u00e9szetes \u00f6l\u0151sejtek aktiv\u00e1l\u00e1sa:<\/span><\/p>\n

Kimutatt\u00e1k, hogy a timozin \u03b11 fokozza a term\u00e9szetes \u00f6l\u0151sejtek (NK) citolitikus aktivit\u00e1s\u00e1t \u00e9s prolifer\u00e1ci\u00f3j\u00e1t, amelyek a velesz\u00fcletett immunv\u00e1lasz fontos effektor sejtjei.<\/span><\/p>\n

A T\u03b11-kezel\u00e9st k\u00f6vet\u0151en megfigyelt\u00e9k az NK-sejtekhez kapcsol\u00f3d\u00f3 markerek, p\u00e9ld\u00e1ul a CD16 \u00e9s a CD56 felregul\u00e1ci\u00f3j\u00e1t.<\/span><\/p>\n

D.\u00a0<\/span>Dendritikus sejtek \u00e9r\u00e9se:<\/span><\/p>\n

A T\u03b11 el\u0151seg\u00edtheti a dendritikus sejtek differenci\u00e1l\u00f3d\u00e1s\u00e1t \u00e9s \u00e9r\u00e9s\u00e9t, amelyek kulcsfontoss\u00e1g\u00fa antig\u00e9nprezent\u00e1l\u00f3 sejtek, amelyek d\u00f6nt\u0151 szerepet j\u00e1tszanak az adapt\u00edv immunv\u00e1laszok elind\u00edt\u00e1s\u00e1ban \u00e9s alak\u00edt\u00e1s\u00e1ban.<\/span><\/p>\n

A ko-stimul\u00e1l\u00f3 molekul\u00e1k fokozott expresszi\u00f3ja \u00e9s a citokinek fokozott szekr\u00e9ci\u00f3ja a dendritikus sejtek \u00e1ltal a T\u03b11-re adott v\u00e1laszk\u00e9nt a T-sejtek jobb aktiv\u00e1ci\u00f3j\u00e1hoz \u00e9s polariz\u00e1ci\u00f3j\u00e1hoz vezethet.<\/span><\/p>\n

2.\u00a0<\/span>Immunmodul\u00e1l\u00f3 jel\u00e1tviteli \u00fatvonalak:<\/span><\/b><\/p>\n

A.\u00a0<\/span>A pontos molekul\u00e1ris mechanizmusok, amelyek r\u00e9v\u00e9n a timozin \u03b11 kifejti immunmodul\u00e1l\u00f3 hat\u00e1s\u00e1t, nem teljesen tiszt\u00e1zottak, de t\u00f6bb jel\u00e1tviteli \u00fatvonal is felmer\u00fclt:<\/span><\/p>\n

a.\u00a0<\/span>A JAK\/STAT (Janus kin\u00e1z\/Signal Transducer and Activator of Transcription) \u00fatvonal aktiv\u00e1l\u00e1sa, ami az immunsejtek m\u0171k\u00f6d\u00e9s\u00e9ben szerepet j\u00e1tsz\u00f3 g\u00e9nek felszab\u00e1lyoz\u00e1s\u00e1hoz vezet.<\/span><\/p>\n

b.\u00a0<\/span>Az NF-\u03baB (Nuclear Factor-kappa B) jel\u00e1tviteli \u00fatvonal modul\u00e1ci\u00f3ja, amely szab\u00e1lyozza a k\u00fcl\u00f6nb\u00f6z\u0151 gyullad\u00e1sos \u00e9s immunrendszerrel kapcsolatos g\u00e9nek kifejez\u0151d\u00e9s\u00e9t.<\/span><\/p>\n

c.\u00a0<\/span>Interakci\u00f3 specifikus sejtfelsz\u00edni receptorokkal, p\u00e9ld\u00e1ul a G-proteinhez kapcsolt CXCR4 receptorral, amely r\u00e9szt vesz az immunsejtek mozg\u00e1s\u00e1ban \u00e9s m\u0171k\u00f6d\u00e9s\u00e9ben.<\/span><\/p>\n

3.\u00a0<\/span>V\u00edrusellenes \u00e9s gyullad\u00e1scs\u00f6kkent\u0151 tulajdons\u00e1gok:<\/span><\/b><\/p>\n

A.\u00a0<\/span>Immunmodul\u00e1l\u00f3 hat\u00e1sai mellett a timozin \u03b11 k\u00f6zvetlen v\u00edrusellenes \u00e9s gyullad\u00e1scs\u00f6kkent\u0151 tulajdons\u00e1gait is kimutatt\u00e1k, amelyek hozz\u00e1j\u00e1rulnak a kr\u00f3nikus v\u00edrushepatitis \u00e9s m\u00e1s gyullad\u00e1sos \u00e1llapotok kezel\u00e9s\u00e9ben rejl\u0151 ter\u00e1pi\u00e1s potenci\u00e1lj\u00e1hoz.<\/span><\/p>\n

B.\u00a0<\/span>A v\u00edrusellenes mechanizmusok magukban foglalhatj\u00e1k a gazdaszervezet immunv\u00e1laszainak fokoz\u00e1s\u00e1t, valamint a v\u00edrus replik\u00e1ci\u00f3j\u00e1nak \u00e9s\/vagy \u00f6sszeszerel\u0151d\u00e9s\u00e9nek k\u00f6zvetlen g\u00e1tl\u00e1s\u00e1t.<\/span><\/p>\n

C.\u00a0<\/span>A T\u03b11 gyullad\u00e1scs\u00f6kkent\u0151 hat\u00e1sait r\u00e9szben a citokin \u00e9s kemokin termel\u00e9s modul\u00e1ci\u00f3j\u00e1n, valamint a gyullad\u00e1sos jel\u00e1tviteli \u00fatvonalak szab\u00e1lyoz\u00e1s\u00e1n kereszt\u00fcl lehet el\u00e9rni.<\/span><\/p>\n

Szab\u00e1lyoz\u00e1si st\u00e1tusz \u00e9s klinikai vizsg\u00e1latok:<\/span><\/b><\/b><\/p>\n

A timozin \u03b11 sz\u00e1mos orsz\u00e1gban, k\u00f6zt\u00fck az Egyes\u00fclt \u00c1llamokban, Eur\u00f3p\u00e1ban \u00e9s K\u00edn\u00e1ban enged\u00e9lyezett gy\u00f3gy\u00e1szati c\u00e9lra, kr\u00f3nikus v\u00edrusos hepatitis kezel\u00e9s\u00e9re.<\/span><\/p>\n

Sz\u00e1mos klinikai vizsg\u00e1latot v\u00e9geztek a T\u03b11 biztons\u00e1goss\u00e1g\u00e1nak \u00e9s hat\u00e9konys\u00e1g\u00e1nak \u00e9rt\u00e9kel\u00e9s\u00e9re k\u00fcl\u00f6nb\u00f6z\u0151 eg\u00e9szs\u00e9g\u00fcgyi \u00e1llapotokban, \u00e9s egyes vizsg\u00e1latok \u00edg\u00e9retes eredm\u00e9nyeket hoztak.<\/span><\/p>\n

Az \u00faj javallatokra vonatkoz\u00f3 hat\u00f3s\u00e1gi j\u00f3v\u00e1hagy\u00e1s \u00e9s a folyamatban l\u00e9v\u0151 kutat\u00e1s a tov\u00e1bbi klinikai vizsg\u00e1latok sikeres befejez\u00e9s\u00e9t\u0151l \u00e9s a szab\u00e1lyoz\u00f3 hat\u00f3s\u00e1gok fel\u00fclvizsg\u00e1lat\u00e1t\u00f3l f\u00fcgg.<\/span><\/p>\n

Gy\u00e1rt\u00e1s \u00e9s ell\u00e1t\u00e1s:<\/span><\/b><\/b><\/p>\n

A timozin \u03b11 el\u0151\u00e1ll\u00edt\u00e1sa \u00e1ltal\u00e1ban rekombin\u00e1ns DNS-technol\u00f3gi\u00e1val t\u00f6rt\u00e9nik, k\u00fcl\u00f6nb\u00f6z\u0151 expresszi\u00f3s rendszerek, p\u00e9ld\u00e1ul bakt\u00e9riumok, \u00e9leszt\u0151 vagy eml\u0151s sejtvonalak felhaszn\u00e1l\u00e1s\u00e1val.<\/span><\/p>\n

A T\u03b11 tiszt\u00edt\u00e1sa \u00e9s formul\u00e1z\u00e1sa t\u00f6bb l\u00e9p\u00e9st foglal mag\u00e1ban a v\u00e9gterm\u00e9k tisztas\u00e1g\u00e1nak, stabilit\u00e1s\u00e1nak \u00e9s biztons\u00e1goss\u00e1g\u00e1nak biztos\u00edt\u00e1sa \u00e9rdek\u00e9ben.<\/span><\/p>\n

A Thymosin \u03b11 kereskedelmi el\u00e9rhet\u0151s\u00e9ge \u00e9s ell\u00e1totts\u00e1ga az adott gy\u00e1rt\u00f3t\u00f3l \u00e9s a k\u00fcl\u00f6nb\u00f6z\u0151 r\u00e9gi\u00f3k hat\u00f3s\u00e1gi enged\u00e9lyeit\u0151l f\u00fcgg\u0151en v\u00e1ltozhat.<\/span><\/b><\/p>\n

A.\u00a0<\/span>Gy\u00e1rt\u00e1si folyamat:<\/span><\/b><\/p>\n

a.\u00a0<\/span>Peptidszint\u00e9zis:<\/span><\/p>\n

a)\u00a0<\/span>A timozin \u03b11-et jellemz\u0151en k\u00e9miai peptidszint\u00e9zissel \u00e1ll\u00edtj\u00e1k el\u0151, gyakran szil\u00e1rd f\u00e1zis\u00fa peptidszint\u00e9zis (SPPS) technik\u00e1val.<\/span><\/p>\n

b)\u00a0<\/span>Az SPPS-ben a T\u03b11 28 aminosavb\u00f3l \u00e1ll\u00f3 szekvenci\u00e1j\u00e1t l\u00e9p\u00e9sr\u0151l l\u00e9p\u00e9sre \u00e1ll\u00edtj\u00e1k \u00f6ssze egy szil\u00e1rd hordoz\u00f3n, p\u00e9ld\u00e1ul egy polimergyant\u00e1n, v\u00e9dett aminosavak \u00e9s meghat\u00e1rozott kapcsol\u00e1si reakci\u00f3k seg\u00edts\u00e9g\u00e9vel.<\/span><\/p>\n

c)\u00a0<\/span>A teljes peptidszekvencia \u00f6ssze\u00e1ll\u00edt\u00e1sa ut\u00e1n a v\u00e9gterm\u00e9ket lev\u00e1lasztj\u00e1k a gyant\u00e1r\u00f3l \u00e9s v\u00e9dtelen\u00edtik, hogy megkapj\u00e1k a k\u00edv\u00e1nt T\u03b11 peptidet.<\/span><\/p>\n

b.\u00a0<\/span>Tiszt\u00edt\u00e1s \u00e9s jellemz\u00e9s:<\/span><\/p>\n

a)\u00a0<\/span>A nyers T\u03b11 peptidet ezut\u00e1n t\u00f6bb tiszt\u00edt\u00e1si l\u00e9p\u00e9snek vetik al\u00e1, jellemz\u0151en nagy teljes\u00edtm\u00e9ny\u0171 folyad\u00e9kkromatogr\u00e1fi\u00e1val (HPLC), a k\u00edv\u00e1nt tisztas\u00e1g \u00e9s min\u0151s\u00e9g el\u00e9r\u00e9se \u00e9rdek\u00e9ben.<\/span><\/p>\n

b)\u00a0<\/span>A T\u03b11 term\u00e9k alapos jellemz\u00e9s\u00e9re, valamint azonoss\u00e1g\u00e1nak, tisztas\u00e1g\u00e1nak \u00e9s szerkezeti integrit\u00e1s\u00e1nak biztos\u00edt\u00e1s\u00e1ra fejlett analitikai technik\u00e1kat, p\u00e9ld\u00e1ul t\u00f6megspektrometri\u00e1t, aminosavelemz\u00e9st \u00e9s cirkul\u00e1ris dikroizmus spektroszk\u00f3pi\u00e1t alkalmaznak.<\/span><\/p>\n

c.\u00a0<\/span>Formul\u00e1z\u00e1s \u00e9s csomagol\u00e1s:<\/span><\/p>\n

a)\u00a0<\/span>A tiszt\u00edtott T\u03b11 peptidet \u00e1ltal\u00e1ban liofiliz\u00e1lt (fagyasztva sz\u00e1r\u00edtott) por form\u00e1j\u00e1ban \u00e1ll\u00edtj\u00e1k el\u0151, ami n\u00f6veli stabilit\u00e1s\u00e1t, \u00e9s megk\u00f6nny\u00edti a t\u00e1rol\u00e1st \u00e9s sz\u00e1ll\u00edt\u00e1st.<\/span><\/p>\n

b)\u00a0<\/span>A formul\u00e1zott T\u03b11 term\u00e9ket ezut\u00e1n aszeptikusan injekci\u00f3s \u00fcvegekbe, ampull\u00e1kba vagy m\u00e1s megfelel\u0151 els\u0151dleges csomagol\u00f3ed\u00e9nyekbe t\u00f6ltik, majd ellen\u0151rz\u00f6tt k\u00f6r\u00fclm\u00e9nyek k\u00f6z\u00f6tt liofiliz\u00e1lj\u00e1k \u00e9s lez\u00e1rj\u00e1k.<\/span><\/p>\n

c)\u00a0<\/span>Speci\u00e1lis csomagol\u00e1st \u00e9s c\u00edmk\u00e9z\u00e9st haszn\u00e1lnak a term\u00e9k integrit\u00e1s\u00e1nak, nyomon k\u00f6vethet\u0151s\u00e9g\u00e9nek \u00e9s a szab\u00e1lyoz\u00e1si k\u00f6vetelm\u00e9nyeknek val\u00f3 megfelel\u00e9snek a biztos\u00edt\u00e1sa \u00e9rdek\u00e9ben.<\/span><\/p>\n

B.\u00a0<\/span>Gy\u00e1rt\u00f3 l\u00e9tes\u00edtm\u00e9nyek \u00e9s min\u0151s\u00e9gellen\u0151rz\u00e9s:<\/span><\/b><\/b><\/p>\n

a.\u00a0<\/span>A timozin \u03b11-et jellemz\u0151en speci\u00e1lis, korszer\u0171 gy\u00f3gyszergy\u00e1rt\u00f3 l\u00e9tes\u00edtm\u00e9nyekben \u00e1ll\u00edtj\u00e1k el\u0151, amelyek betartj\u00e1k a helyes gy\u00e1rt\u00e1si gyakorlat (GMP) ir\u00e1nyelveit.<\/span><\/p>\n

b.\u00a0<\/span>Ezek a l\u00e9tes\u00edtm\u00e9nyek speci\u00e1lis berendez\u00e9sekkel vannak felszerelve, \u00e9s szigor\u00fa min\u0151s\u00e9gellen\u0151rz\u00e9si int\u00e9zked\u00e9seket alkalmaznak, bele\u00e9rtve a folyamat k\u00f6zbeni vizsg\u00e1latokat, a v\u00e9gs\u0151 term\u00e9kkibocs\u00e1t\u00e1s vizsg\u00e1lat\u00e1t \u00e9s a folyamatos stabilit\u00e1sellen\u0151rz\u00e9st.<\/span><\/p>\n

c.\u00a0<\/span>A gy\u00e1rt\u00e1si folyamatot \u00e9s a min\u0151s\u00e9gellen\u0151rz\u00e9si rendszereket a szab\u00e1lyoz\u00f3 hat\u00f3s\u00e1gok rendszeresen ellen\u0151rzik \u00e9s audit\u00e1lj\u00e1k, hogy biztos\u00edts\u00e1k a vonatkoz\u00f3 szabv\u00e1nyoknak \u00e9s ir\u00e1nyelveknek val\u00f3 megfelel\u00e9st.<\/span><\/p>\n

C.\u00a0<\/span>Ell\u00e1t\u00e1si l\u00e1nc \u00e9s forgalmaz\u00e1s:<\/span><\/b><\/b><\/p>\n

a.\u00a0<\/span>A Thymosin \u03b11 ell\u00e1t\u00e1s\u00e1t els\u0151sorban korl\u00e1tozott sz\u00e1m\u00fa, a sz\u00fcks\u00e9ges hat\u00f3s\u00e1gi enged\u00e9lyekkel \u00e9s gy\u00e1rt\u00e1si k\u00e9pess\u00e9gekkel rendelkez\u0151, szakosodott gy\u00f3gyszeripari v\u00e1llalat \u00e9s kutat\u00f3szervezet ellen\u0151rzi.<\/span><\/p>\n

b.\u00a0<\/span>A T\u03b11-term\u00e9kek forgalmaz\u00e1sa jellemz\u0151en a kialakult gy\u00f3gyszerell\u00e1t\u00e1si l\u00e1ncokon kereszt\u00fcl t\u00f6rt\u00e9nik, nagykeresked\u0151k, forgalmaz\u00f3k \u00e9s enged\u00e9lyezett eg\u00e9szs\u00e9g\u00fcgyi int\u00e9zm\u00e9nyek vagy gy\u00f3gyszert\u00e1rak bevon\u00e1s\u00e1val.<\/span><\/p>\n

c.\u00a0<\/span>A T\u03b11-hez val\u00f3 hozz\u00e1f\u00e9r\u00e9s az adott orsz\u00e1gt\u00f3l vagy r\u00e9gi\u00f3t\u00f3l f\u00fcgg\u0151en v\u00e1ltozhat, mivel a k\u00fcl\u00f6nb\u00f6z\u0151 piacokon a hat\u00f3s\u00e1gi j\u00f3v\u00e1hagy\u00e1st\u00f3l \u00e9s a kereskedelmi el\u00e9rhet\u0151s\u00e9gt\u0151l f\u00fcgg.<\/span><\/p>\n

D.\u00a0<\/span>Szab\u00e1lyoz\u00e1si megfontol\u00e1sok:<\/span><\/b><\/b><\/p>\n

a.\u00a0<\/span>A timozin \u03b11 biogy\u00f3gy\u00e1szati term\u00e9kk\u00e9nt szab\u00e1lyozott, \u00e9s a fejleszt\u00e9s, gy\u00e1rt\u00e1s \u00e9s forgalomba hozatal enged\u00e9lyez\u00e9se tekintet\u00e9ben szigor\u00fa szab\u00e1lyoz\u00e1si k\u00f6vetelm\u00e9nyek vonatkoznak r\u00e1 a k\u00fcl\u00f6nb\u00f6z\u0151 joghat\u00f3s\u00e1gokban.<\/span><\/p>\n

b.\u00a0<\/span>A T\u03b11 gy\u00e1rt\u00e1si \u00e9s min\u0151s\u00e9gellen\u0151rz\u00e9si folyamatainak meg kell felelni\u00fck az alkalmazand\u00f3 GMP-ir\u00e1nyelveknek, \u00e9s azokat a szab\u00e1lyoz\u00f3 hat\u00f3s\u00e1goknak, p\u00e9ld\u00e1ul az Egyes\u00fclt \u00c1llamok \u00c9lelmiszer- \u00e9s Gy\u00f3gyszer\u00fcgyi Hivatal\u00e1nak (FDA) \u00e9s az Eur\u00f3pai Gy\u00f3gyszer\u00fcgyn\u00f6ks\u00e9gnek (EMA) j\u00f3v\u00e1 kell hagyniuk.<\/span><\/p>\n

c.\u00a0<\/span>A folyamatos farmakovigilancia \u00e9s a forgalomba hozatalt k\u00f6vet\u0151 fel\u00fcgyelet szint\u00e9n alapvet\u0151 fontoss\u00e1g\u00fa a piacon l\u00e9v\u0151 T\u03b11-term\u00e9kek biztons\u00e1goss\u00e1g\u00e1nak \u00e9s hat\u00e9konys\u00e1g\u00e1nak nyomon k\u00f6vet\u00e9se szempontj\u00e1b\u00f3l.<\/span><\/p>","protected":false},"excerpt":{"rendered":"

Thymosin alpha1 Overview: Thymosin-alpha1 (T-alpha1) is a synthetic 28-amino-acid peptide with multiple biological activities, used primarily to boost the immune response in the treatment of HBV and hepatitis C virus (HCV) infections and currently in development for the treatment of non-small cell lung cancer (NSCLC), hepatocellular carcinoma, AIDS and malignant melanoma. T-alpha1 potentiates cytokine activity […]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"yoast_head":"\nRevolutionizing Immune Therapy: Thymosin Alpha1 Unleashes the Power of Precision Medicine in Fighting Viral Infections, Cancer, and Beyond! - China Chemical Manufacturer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/longchangextracts.com\/hu\/thymosin-alpha1\uff1arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/\" \/>\n<meta property=\"og:locale\" content=\"hu_HU\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revolutionizing Immune Therapy: Thymosin Alpha1 Unleashes the Power of Precision Medicine in Fighting Viral Infections, Cancer, and Beyond! - China Chemical Manufacturer\" \/>\n<meta property=\"og:description\" content=\"Thymosin alpha1 Overview: Thymosin-alpha1 (T-alpha1) is a synthetic 28-amino-acid peptide with multiple biological activities, used primarily to boost the immune response in the treatment of HBV and hepatitis C virus (HCV) infections and currently in development for the treatment of non-small cell lung cancer (NSCLC), hepatocellular carcinoma, AIDS and malignant melanoma. T-alpha1 potentiates cytokine activity […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/longchangextracts.com\/hu\/thymosin-alpha1\uff1arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/\" \/>\n<meta property=\"og:site_name\" content=\"China Chemical Manufacturer\" \/>\n<meta property=\"article:published_time\" content=\"2024-04-12T07:03:00+00:00\" \/>\n<meta name=\"author\" content=\"longcha9\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Szerz\u0151:\" \/>\n\t<meta name=\"twitter:data1\" content=\"longcha9\" \/>\n\t<meta name=\"twitter:label2\" content=\"Becs\u00fclt olvas\u00e1si id\u0151\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 perc\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/longchangextracts.com\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/\",\"url\":\"https:\/\/longchangextracts.com\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/\",\"name\":\"Revolutionizing Immune Therapy: Thymosin Alpha1 Unleashes the Power of Precision Medicine in Fighting Viral Infections, Cancer, and Beyond! - China Chemical Manufacturer\",\"isPartOf\":{\"@id\":\"https:\/\/longchangextracts.com\/#website\"},\"datePublished\":\"2024-04-12T07:03:00+00:00\",\"dateModified\":\"2024-04-12T07:03:00+00:00\",\"author\":{\"@id\":\"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869\"},\"breadcrumb\":{\"@id\":\"https:\/\/longchangextracts.com\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/#breadcrumb\"},\"inLanguage\":\"hu\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/longchangextracts.com\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/longchangextracts.com\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/longchangextracts.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revolutionizing Immune Therapy: Thymosin Alpha1 Unleashes the Power of Precision Medicine in Fighting Viral Infections, Cancer, and Beyond!\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/longchangextracts.com\/#website\",\"url\":\"https:\/\/longchangextracts.com\/\",\"name\":\"China Chemical Manufacturer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/longchangextracts.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"hu\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869\",\"name\":\"longcha9\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"hu\",\"@id\":\"https:\/\/longchangextracts.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g\",\"caption\":\"longcha9\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Az immunter\u00e1pia forradalmas\u00edt\u00e1sa: A timozin alfa1 felszabad\u00edtja a prec\u00edzi\u00f3s orvostudom\u00e1ny erej\u00e9t a v\u00edrusfert\u0151z\u00e9sek, a r\u00e1k \u00e9s azon t\u00fal! - K\u00edna Vegyi Gy\u00e1rt\u00f3","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/longchangextracts.com\/hu\/thymosin-alpha1\uff1arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/","og_locale":"hu_HU","og_type":"article","og_title":"Revolutionizing Immune Therapy: Thymosin Alpha1 Unleashes the Power of Precision Medicine in Fighting Viral Infections, Cancer, and Beyond! - China Chemical Manufacturer","og_description":"Thymosin alpha1 Overview: Thymosin-alpha1 (T-alpha1) is a synthetic 28-amino-acid peptide with multiple biological activities, used primarily to boost the immune response in the treatment of HBV and hepatitis C virus (HCV) infections and currently in development for the treatment of non-small cell lung cancer (NSCLC), hepatocellular carcinoma, AIDS and malignant melanoma. T-alpha1 potentiates cytokine activity […]","og_url":"https:\/\/longchangextracts.com\/hu\/thymosin-alpha1\uff1arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/","og_site_name":"China Chemical Manufacturer","article_published_time":"2024-04-12T07:03:00+00:00","author":"longcha9","twitter_card":"summary_large_image","twitter_misc":{"Szerz\u0151:":"longcha9","Becs\u00fclt olvas\u00e1si id\u0151":"9 perc"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/longchangextracts.com\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/","url":"https:\/\/longchangextracts.com\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/","name":"Az immunter\u00e1pia forradalmas\u00edt\u00e1sa: A timozin alfa1 felszabad\u00edtja a prec\u00edzi\u00f3s orvostudom\u00e1ny erej\u00e9t a v\u00edrusfert\u0151z\u00e9sek, a r\u00e1k \u00e9s azon t\u00fal! - K\u00edna Vegyi Gy\u00e1rt\u00f3","isPartOf":{"@id":"https:\/\/longchangextracts.com\/#website"},"datePublished":"2024-04-12T07:03:00+00:00","dateModified":"2024-04-12T07:03:00+00:00","author":{"@id":"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869"},"breadcrumb":{"@id":"https:\/\/longchangextracts.com\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/#breadcrumb"},"inLanguage":"hu","potentialAction":[{"@type":"ReadAction","target":["https:\/\/longchangextracts.com\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/longchangextracts.com\/thymosin-alpha1%ef%bc%9arevolutionizing-immune-therapy-thymosin-alpha1-unleashes-the-power-of-precision-medicine-in-fighting-viral-infections-cancer-and-beyond\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/longchangextracts.com\/"},{"@type":"ListItem","position":2,"name":"Revolutionizing Immune Therapy: Thymosin Alpha1 Unleashes the Power of Precision Medicine in Fighting Viral Infections, Cancer, and Beyond!"}]},{"@type":"WebSite","@id":"https:\/\/longchangextracts.com\/#website","url":"https:\/\/longchangextracts.com\/","name":"K\u00edna Vegyi Gy\u00e1rt\u00f3","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/longchangextracts.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"hu"},{"@type":"Person","@id":"https:\/\/longchangextracts.com\/#\/schema\/person\/80933ac6926ad63fea74ec33f8d04869","name":"longcha9","image":{"@type":"ImageObject","inLanguage":"hu","@id":"https:\/\/longchangextracts.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1e84ee0759373263198c58e8f338f80?s=96&d=mm&r=g","caption":"longcha9"}}]}},"_links":{"self":[{"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/posts\/3388"}],"collection":[{"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/comments?post=3388"}],"version-history":[{"count":0,"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/posts\/3388\/revisions"}],"wp:attachment":[{"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/media?parent=3388"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/categories?post=3388"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/longchangextracts.com\/hu\/wp-json\/wp\/v2\/tags?post=3388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}